https://scholars.lib.ntu.edu.tw/handle/123456789/416950
標題: | Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A*0201-restricted T-cell peptides in cervical cancer patients | 作者: | Liu D.-W. Yang Y.-C. Lin H.-F. Lin M.-F. Cheng Y.-W. Chu C.-N. Tsao Y.-P. SHOW-LI CHEN |
公開日期: | 2007 | 卷: | 81 | 期: | 6 | 起(迄)頁: | 2869-2879 | 來源出版物: | Journal of Virology | 摘要: | Previously, we found that human papillomavirus type 16 (HPV-16) E5 protein is a tamor rejection antigen and can induce cytotoxic T-lymphocyte (CTL) activity. Therefore, in this study, human leukocyte antigen A*0201 (HLA-A*0201)-restricted human CTL epitopes of HPV-16 E5 protein were identified using a bioinformatics approach, and the abilities of these predicted peptides to induce an immune response in HLA-A*0201 transgenic mice were confirmed by assaying E5-specific CTLs and in vitro-generated CTLs from normal peripheral blood T lymphocytes of HLA-A2-positive human donors. Second, the CTL responses to HLA-A*0201 CTL epitopes (E5 63-71 and E7 11-20) were examined in HPV-16-infected patients with HLA-A2. Third, the effect of HLA-A-type alleles on CTL activities in response to the entire E5 and E7 proteins was examined in cervical cancer patients. E5 and E7 peptides (but not the whole proteins) stimulated E5- and E7-specific CTL recall responses in HPV-16- and HLA-A2-positive cervical cancer patients, and HPV-16 E5 and E7 proteins stimulated na?ve T cells in HPV-16-megative cervical cancer patients with HLA-A11 and -A24 haplotypes. In summary, this is the first demonstration that E5 63-71 is an HLA-A*0201-restricted T-cell epitope of HPV-16 E5. Copyright ? 2007, American Society for Microbiology. All Rights Reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-33947371281&doi=10.1128%2fJVI.02256-06&partnerID=40&md5=3fecd1f6d738572806500d2894b957c9 https://scholars.lib.ntu.edu.tw/handle/123456789/416950 |
ISSN: | 0022-538X | DOI: | 10.1128/JVI.02256-06 | SDG/關鍵字: | HLA A0201 antigen; HLA antigen; protein E5; protein E7; tumor rejection antigen; unclassified drug; virus protein; adult; aged; allele; animal cell; article; controlled study; cytotoxic T lymphocyte; female; haplotype; human; human cell; Human papillomavirus type 16; immune response; mouse; nonhuman; priority journal; T lymphocyte; uterine cervix cancer; Adenoviridae; Adult; Aged; Alleles; Animals; Carcinoma; Epitopes; Female; HLA-A Antigens; Human papillomavirus 16; Humans; Interferon Type II; Mice; Mice, Transgenic; Middle Aged; Neoplasm Staging; Oncogene Proteins, Viral; T-Lymphocytes, Cytotoxic; Uterine Cervical Neoplasms; Human papillomavirus type 16; Mus musculus |
顯示於: | 微生物學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。